143 related articles for article (PubMed ID: 24587834)
1. Continuous heliox breathing and the extent of anatomic zone of noreflow and necrosis following ischemia/reperfusion in the rabbit heart.
Hale SL; Vanderipe DR; Kloner RA
Open Cardiovasc Med J; 2013; 8():1-5. PubMed ID: 24587834
[TBL] [Abstract][Full Text] [Related]
2. Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction.
Hale SL; Dae MW; Kloner RA
Cardiovasc Res; 2003 Sep; 59(3):715-22. PubMed ID: 14499873
[TBL] [Abstract][Full Text] [Related]
3. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
Hale SL; Mehra A; Leeka J; Kloner RA
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H421-5. PubMed ID: 17993599
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion.
Hale SL; Kloner RA
J Thromb Thrombolysis; 2015 Jan; 39(1):50-4. PubMed ID: 25017632
[TBL] [Abstract][Full Text] [Related]
5. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model.
Dai W; Amoedo ND; Perry J; Le Grand B; Boucard A; Carreno J; Zhao L; Brown DA; Rossignol R; Kloner RA
Cardiovasc Drugs Ther; 2022 Apr; 36(2):217-227. PubMed ID: 33555510
[TBL] [Abstract][Full Text] [Related]
6. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
[TBL] [Abstract][Full Text] [Related]
7. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining.
Birnbaum Y; Hale SL; Kloner RA
J Mol Cell Cardiol; 1997 Feb; 29(2):657-66. PubMed ID: 9140823
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):60-7. PubMed ID: 20133497
[TBL] [Abstract][Full Text] [Related]
9. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen and experimental acute myocardial infarction.
Hale SL; Kloner RA
Cardiovasc Drugs Ther; 2004 Mar; 18(2):121-5. PubMed ID: 15162073
[TBL] [Abstract][Full Text] [Related]
11. Rapid Induction of Hypothermia by the ThermoSuit System Profoundly Reduces Infarct Size and Anatomic Zone of No Reflow Following Ischemia-Reperfusion in Rabbit and Rat Hearts.
Herring MJ; Dai W; Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):193-202. PubMed ID: 24906542
[TBL] [Abstract][Full Text] [Related]
12. Diannexin reduces no-reflow after reperfusion in rabbits with large ischemic myocardial risk zones.
Hale SL; Allison AC; Kloner RA
Cardiovasc Ther; 2011 Aug; 29(4):e42-52. PubMed ID: 20946319
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.
Litt MR; Jeremy RW; Weisman HF; Winkelstein JA; Becker LC
Circulation; 1989 Dec; 80(6):1816-27. PubMed ID: 2598440
[TBL] [Abstract][Full Text] [Related]
15. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
[TBL] [Abstract][Full Text] [Related]
16. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.
Reffelmann T; Hale SL; Li G; Kloner RA
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H766-72. PubMed ID: 11788428
[TBL] [Abstract][Full Text] [Related]
17. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
Dai W; Hale S; Kloner RA
Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
[TBL] [Abstract][Full Text] [Related]
18. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide.
Elliott GT; Comerford ML; Smith JR; Zhao L
Cardiovasc Res; 1996 Dec; 32(6):1071-80. PubMed ID: 9015409
[TBL] [Abstract][Full Text] [Related]
19. The effect of CY1503, a sialyl Lewisx analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion.
Birnbaum Y; Patterson M; Kloner RA
J Mol Cell Cardiol; 1997 Aug; 29(8):2013-25. PubMed ID: 9281435
[TBL] [Abstract][Full Text] [Related]
20. Short-term synchronized retroperfusion before reperfusion reduces infarct size after prolonged ischemia in dogs.
Wakida Y; Nordlander R; Kobayashi S; Kar S; Haendchen R; Corday E
Circulation; 1993 Nov; 88(5 Pt 1):2370-80. PubMed ID: 8222130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
